<DOC>
	<DOCNO>NCT02251041</DOCNO>
	<brief_summary>The purpose study establish effectiveness combine drug approach ( anti-thrombin III , infliximab , apotransferrin , human recombinant erythropoietin beta , C1-inhibitor , glutathione , alfa-tocopherol , melatonin epoprostenol ) aim reduce ischemia-reperfusion injury liver transplantation eligible recipient .</brief_summary>
	<brief_title>Combined Drug Approach Prevent Ischemia-reperfusion Injury During Transplantation Livers ( CAPITL )</brief_title>
	<detailed_description />
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Reperfusion Injury</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<mesh_term>Tocopherols</mesh_term>
	<mesh_term>Melatonin</mesh_term>
	<mesh_term>alpha-Tocopherol</mesh_term>
	<mesh_term>Vitamin E</mesh_term>
	<mesh_term>Antithrombins</mesh_term>
	<mesh_term>Antithrombin III</mesh_term>
	<mesh_term>Infliximab</mesh_term>
	<criteria>1 . Patients suffer irreversible liver failure eligible liver transplantation accord Eurotransplant guideline . 2 . Patients &gt; 18 year age time list Eurotransplant wait list liver transplantation University Hospitals Leuven , Belgium . 1 . Patients refuse participate study . 2 . History hypersensitivity one/several component ( ) combine drug approach . 3 . Conditions prevent use combine drug approach : Administration heparin therapeutic dose preoperatively , Congestive heart failure , History seizure , poorly control arterial hypertension , myocardial infarction stroke month precede liver transplantation , venous thromboembolic disease , Unstable angina pectoris , Sepsis , abcesses opportunistic infection , History infliximab treatment , Use vitamin K antagonist anticoagulation . 4 . Mental condition render subject incapable understand nature , scope , consequence trial . 5 . Combined organ transplantation . 6 . Retransplantation . 7 . Patients dialysisdependent prior liver transplantation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Liver</keyword>
	<keyword>Transplantation</keyword>
	<keyword>Ischemia-reperfusion</keyword>
	<keyword>Effectiveness</keyword>
</DOC>